We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+10.63%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$26.8B
AUM Growth
+$3.09B
Cap. Flow
+$1.26B
Cap. Flow %
4.69%
Top 10 Hldgs %
40.07%
Holding
1,108
New
38
Increased
406
Reduced
634
Closed
28

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$209M
2
MCHP icon
Microchip Technology
MCHP
+$129M
3
ADI icon
Analog Devices
ADI
+$119M
4
QCOM icon
Qualcomm
QCOM
+$112M
5
TXN icon
Texas Instruments
TXN
+$108M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$309M
2
NVDA icon
NVIDIA
NVDA
+$93.3M
3
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$78.6M
4
FXI icon
iShares China Large-Cap ETF
FXI
+$69.7M
5
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$35M

Sector Composition

Rank Sector Weight
1 Technology 47.45%
2 Financials 9.33%
3 Healthcare 6.2%
4 Consumer Discretionary 3.62%
5 Energy 2.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTCT icon
326
PTC Therapeutics
PTCT
$5.68B
$8.56M 0.03%
294,304
-45,659
-13% -$1.28M
VLY icon
327
Valley National Bancorp
VLY
$8.02B
$8.53M 0.03%
1,071,139
+259,891
+32% +$2.32M
RJF icon
328
Raymond James Financial
RJF
$34.1B
$8.5M 0.03%
66,197
-397
-0.6% -$46.3K
ZTS icon
329
Zoetis
ZTS
$32.3B
$8.49M 0.03%
50,167
+1,209
+2% +$226K
ALKS icon
330
Alkermes
ALKS
$8.31B
$8.49M 0.03%
313,523
-33,654
-10% -$956K
AX icon
331
Axos Financial
AX
$5.9B
$8.48M 0.03%
156,878
-5,926
-4% -$312K
KYMR icon
332
Kymera Therapeutics
KYMR
$8.25B
$8.48M 0.03%
210,861
+90,672
+75% +$3.24M
RARE icon
333
Ultragenyx Pharmaceutical
RARE
$2.46B
$8.47M 0.03%
181,484
-40,426
-18% -$1.91M
NDAQ icon
334
Nasdaq
NDAQ
$52.6B
$8.43M 0.03%
133,655
+12,991
+11% +$752K
CRSP icon
335
CRISPR Therapeutics
CRSP
$4.88B
$8.42M 0.03%
123,574
-23,763
-16% -$1.7M
TWST icon
336
Twist Bioscience
TWST
$6.29B
$8.37M 0.03%
244,092
+14,483
+6% +$523K
TGTX icon
337
TG Therapeutics
TGTX
$7.07B
$8.31M 0.03%
546,519
-24,607
-4% -$392K
GLW icon
338
Corning
GLW
$126B
$8.25M 0.03%
250,195
+10,163
+4% +$324K
STT icon
339
State Street
STT
$50.5B
$8.21M 0.03%
106,222
-3,170
-3% -$235K
SSB icon
340
SouthState Bank Corp
SSB
$10.5B
$8.19M 0.03%
96,322
-7,668
-7% -$632K
NUVL
341
DELISTED
Nuvalent
NUVL
$8.16M 0.03%
108,668
-18,378
-14% -$1.46M
ARQT icon
342
Arcutis Biotherapeutics
ARQT
$3.24B
$8.15M 0.03%
+822,461
New +$6.14M
BEAM icon
343
Beam Therapeutics
BEAM
$2.67B
$8.07M 0.03%
244,354
-95,363
-28% -$2.97M
NVAX icon
344
Novavax
NVAX
$1.22B
$8.04M 0.03%
1,682,659
+70,819
+4% +$328K
CLDX icon
345
Celldex Therapeutics
CLDX
$2.96B
$8.03M 0.03%
191,415
+43,406
+29% +$1.78M
ONB icon
346
Old National Bancorp
ONB
$10.3B
$8M 0.03%
459,477
+5,335
+1% +$88.3K
BCRX icon
347
BioCryst Pharmaceuticals
BCRX
$2.24B
$7.97M 0.03%
1,569,782
+614,195
+64% +$3.45M
KMI icon
348
Kinder Morgan
KMI
$69.9B
$7.96M 0.03%
433,886
-70,596
-14% -$1.23M
GERN icon
349
Geron
GERN
$821M
$7.96M 0.03%
2,411,211
+742,124
+44% +$1.66M
KROS icon
350
Keros Therapeutics
KROS
$200M
$7.91M 0.03%
119,511
+54,230
+83% +$3.22M
12 13
14
15 16

Similar funds

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return

Rafferty Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Rafferty Asset Management held 1,108 positions worth $26.8B, up 13% from $23.7B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Rafferty Asset Management deployed $1.26B of net new capital in Q1 2024, opening 38 new positions and adding to 406 existing holdings. Its largest new stake was Super Micro Computer: 164,060 shares worth $16.6M.

By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 40% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $309M trimmed.

  • Rafferty Asset Management's largest Q1 2024 buy was Super Micro Computer: 164,060 shares worth $16.6M.
  • Rafferty Asset Management added most to Intel in Q1 2024, an estimated $209M increase.
  • Rafferty Asset Management's biggest Q1 2024 reduction was iShares Russell 2000 ETF, cutting an estimated $309M.
  • Rafferty Asset Management fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $13.8M.
  • Rafferty Asset Management's ten largest holdings make up 40% of its $26.8B portfolio in Q1 2024.
  • Rafferty Asset Management opened 38 new positions and closed 28 in Q1 2024.
  • Rafferty Asset Management's portfolio value rose 13% quarter-over-quarter to $26.8B.

Based on Rafferty Asset Management's 13F filing for Q1 2024, filed 13 May 2024.